GDPD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.18450005359705E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.16110000012182E-07 |
Normal-vs-Stage2 |
1.422140E-03 |
Normal-vs-Stage3 |
1.66244795707371E-12 |
Normal-vs-Stage4 |
1.94339999648463E-08 |
Stage1-vs-Stage2 |
8.539600E-01 |
Stage1-vs-Stage3 |
1.601950E-03 |
Stage1-vs-Stage4 |
4.828500E-02 |
Stage2-vs-Stage3 |
4.591900E-02 |
Stage2-vs-Stage4 |
1.479450E-01 |
Stage3-vs-Stage4 |
5.317200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.0245995425181E-10 |
Normal-vs-AfricanAmerican |
6.12139999999206E-05 |
Normal-vs-Asian |
7.575400E-01 |
Caucasian-vs-AfricanAmerican |
9.091000E-01 |
Caucasian-vs-Asian |
3.566600E-01 |
AfricanAmerican-vs-Asian |
2.156400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.35020000630237E-09 |
Normal-vs-Female |
2.49710000455039E-08 |
Male-vs-Female |
9.671000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.15380005549781E-09 |
Normal-vs-Age(41-60Yrs) |
9.31290000671936E-09 |
Normal-vs-Age(61-80Yrs) |
2.89049995050306E-09 |
Normal-vs-Age(81-100Yrs) |
2.497400E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.902540E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.662030E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.282200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.498800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.373200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.916400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.852200E-01 |
Normal-vs-Grade 2 |
8.08819999975618E-07 |
Normal-vs-Grade 3 |
2.3572000018568E-08 |
Normal-vs-Grade 4 |
1.63713487211226E-12 |
Grade 1-vs-Grade 2 |
1.245380E-01 |
Grade 1-vs-Grade 3 |
5.679800E-02 |
Grade 1-vs-Grade 4 |
1.833990E-04 |
Grade 2-vs-Grade 3 |
2.427400E-01 |
Grade 2-vs-Grade 4 |
2.09929999999137E-05 |
Grade 3-vs-Grade 4 |
1.361890E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.033900E-04 |
Normal-vs-ccB subtype |
7.73909825113606E-11 |
ccA subtype-vs-ccB subtype |
1.998530E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.88660000347107E-08 |
Normal-vs-N1 |
1.82974999999308E-05 |
N0-vs-N1 |
1.757770E-01 |
|
|